Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Gordon

Showing results (121-130 of 234) with videos related to

Pageof 24
Sort By:
Arthritis Research & Therapy|July 25, 2006
Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritisKarim Raza, Dagmar Scheel-Toellner, Chi-Yeung Lee, et al.
Rheumatology (Oxford, England)|October 14, 2017
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adultsCaroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Lupus Science & Medicine|December 5, 2019
Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance ProgramPeter Izmirly, Jill Buyon, H Michael Belmont, et al.
Journal of Autoimmunity|December 8, 2023
Associations between CD70 methylation of T cell DNA and age in adults with systemic lupus erythematosus and population controls: The Michigan Lupus Epidemiology & Surveillance (MILES) ProgramEmily C Somers, Jaclyn M Goodrich, Lu Wang, et al.
Rheumatology (Oxford, England)|June 13, 2018
Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: replyCaroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Rheumatology (Oxford, England)|October 14, 2017
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive SummaryCaroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Rheumatology (Oxford, England)|April 2, 2013
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-upDaniel J Wallace, Caroline Gordon, Vibeke Strand, et al.
Arthritis and Rheumatism|December 30, 2009
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trialJoan T Merrill, C Michael Neuwelt, Daniel J Wallace, et al.
Eclinicalmedicine|October 21, 2024
Neuropsychiatric prodromes and symptom timings in relation to disease onset and/or flares in SLE: results from the mixed methods international INSPIRE studyMelanie Sloan, James A Bourgeois, Guy Leschziner, et al.
Arthritis and Rheumatism|December 1, 2007
British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosusChee-Seng Yee, Vernon Farewell, David A Isenberg, et al.
Pageof 24

Showing results (121-130 of 234) with videos related to

Sort By:
Pageof 24
Arthritis Research & Therapy|July 25, 2006
Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritisKarim Raza, Dagmar Scheel-Toellner, Chi-Yeung Lee, et al.
Rheumatology (Oxford, England)|October 14, 2017
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adultsCaroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Lupus Science & Medicine|December 5, 2019
Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance ProgramPeter Izmirly, Jill Buyon, H Michael Belmont, et al.
Journal of Autoimmunity|December 8, 2023
Associations between CD70 methylation of T cell DNA and age in adults with systemic lupus erythematosus and population controls: The Michigan Lupus Epidemiology & Surveillance (MILES) ProgramEmily C Somers, Jaclyn M Goodrich, Lu Wang, et al.
Rheumatology (Oxford, England)|June 13, 2018
Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: replyCaroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Rheumatology (Oxford, England)|October 14, 2017
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive SummaryCaroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Rheumatology (Oxford, England)|April 2, 2013
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-upDaniel J Wallace, Caroline Gordon, Vibeke Strand, et al.
Arthritis and Rheumatism|December 30, 2009
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trialJoan T Merrill, C Michael Neuwelt, Daniel J Wallace, et al.
Eclinicalmedicine|October 21, 2024
Neuropsychiatric prodromes and symptom timings in relation to disease onset and/or flares in SLE: results from the mixed methods international INSPIRE studyMelanie Sloan, James A Bourgeois, Guy Leschziner, et al.
Arthritis and Rheumatism|December 1, 2007
British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosusChee-Seng Yee, Vernon Farewell, David A Isenberg, et al.
Pageof 24